What Is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH). In its most studied form — often referred to as CJC-1295 with DAC — the peptide is modified with a Drug Affinity Complex that allows it to bind to circulating albumin after injection. This albumin-binding feature is what distinguishes CJC-1295 from native GHRH and from shorter-acting GHRH analogs like sermorelin.
You can read a full compound profile in our detailed CJC-1295 compound page. For now, the key point is that CJC-1295 was designed to extend the half-life of GHRH signaling — turning what would normally be a brief pulse into a more sustained elevation.
What Does the Published Evidence Show?
The most frequently cited human study on CJC-1295 was conducted by PMID: 16352683 and published in the Journal of Clinical Endocrinology & Metabolism. In this randomized, double-blind, placebo-controlled trial, healthy adult subjects received CJC-1295 at varying doses. The key findings included:
- Dose-dependent increases in GH and IGF-1: Mean GH concentrations rose significantly in a dose-dependent manner following CJC-1295 administration. IGF-1 levels were elevated for up to 11–14 days after a single injection at the highest doses tested.
- Prolonged pharmacodynamic effect: The sustained elevation of IGF-1 was the defining observation — it indicated that the DAC mechanism was functioning as designed in humans, not just in rodent models.
- Generally well-tolerated at studied doses: The authors reported that CJC-1295 was tolerated in the dose ranges studied, with transient injection-site reactions being the most commonly noted observation.
It’s worth noting that this was a relatively small study in healthy volunteers, not a large-scale efficacy trial. The researchers were characterizing pharmacokinetics and pharmacodynamics, not testing clinical outcomes. Subsequent discussions in the literature have focused more on the peptide’s potential as a research tool than on therapeutic claims.
A broader context comes from decades of GHRH research reviewed by PMID: 9861545, whose comprehensive review of the neuroregulation of GH secretion established much of the foundational science that CJC-1295 builds upon. Their work highlights how GHRH signaling interacts with somatostatin tone, ghrelin, and feedback from IGF-1 to produce the complex pulsatile GH pattern seen in healthy adults.
What the evidence does not support: Any direct clinical claims about CJC-1295. There are no completed, peer-reviewed large-scale clinical trials demonstrating specific health outcomes. Most of the commercially available CJC-1295 sold today is designated for research use only, and responsible interpretation of the literature should reflect that limitation.
A Step-by-Step Evaluation Framework
If you want to apply the criteria above systematically, here’s a practical checklist:
- Request the COA before purchasing. A legitimate vendor will have batch-specific documentation ready.
- Verify the testing lab. Is it an independent facility? Can you look up the lab’s credentials?
- Check the purity method. Is it HPLC? What wavelength was used for detection?
- Confirm the molecular weight. The COA should show mass spec data consistent with CJC-1295’s known molecular weight.
- Compare total cost — including shipping, cold-chain logistics, and any bulk discounts.
- Start with a small order. Even with great documentation, a trial order lets you verify packaging quality, delivery speed, and product appearance before committing to larger quantities.
The Bottom Line
Choosing a CJC-1295 supplier comes down to verifiable documentation, transparent practices, and reasonable pricing — not flashy websites or bold promises. The research literature, including the pharmacokinetic work by Teichman et al. and the foundational mechanism studies by Jetté et al., provides a solid scientific framework for understanding what this peptide is and what it does. Your job as a researcher is to ensure the physical product in your hands matches the quality of that published science.
Weigh third-party testing data heavily. Don’t pay a premium for marketing language. And when in doubt, consult a detailed supplier comparison guide that cross-references multiple vendors against objective criteria.
The goal isn’t to find the “best” supplier in absolute terms — it’s to find the supplier whose documentation, quality control, and transparency meet the standards your research demands.
Imagine You’re Planning a New Experiment
You’ve just reviewed the published literature on growth hormone secretagogues, and CJC-1295 has caught your attention. The preclinical data looks interesting, the pharmacokinetic profile is well-characterized, and you’ve secured lab space and a budget. There’s just one practical problem standing between your research plan and your first vial: which supplier do you actually order from?
If you’ve spent any time browsing research peptide vendors, you know the landscape is noisy. Dozens of websites sell CJC-1295 — sometimes called CJC-1295 with DAC (Drug Affinity Complex) — and the claims on those sites range from meticulous to reckless. Some list HPLC purity data front and center. Others bury their sourcing details or don’t provide certificates of analysis at all. Prices vary by a factor of four or more, and it’s not always clear why.
This guide exists to help you cut through that noise. We’ll start with a brief refresher on what CJC-1295 is and how it works, walk through the published evidence, and then compare the practical factors you should weigh before placing an order. No rankings, no sponsored picks — just the framework a careful researcher needs.
How CJC-1295 Works: The Mechanism
CJC-1295 acts on the same receptor as endogenous GHRH: the growth hormone–releasing hormone receptor (GHRH-R) located on somatotroph cells in the anterior pituitary gland. When the peptide binds to GHRH-R, it activates adenylyl cyclase, increases intracellular cyclic AMP (cAMP), and stimulates the release of stored growth hormone (GH) into systemic circulation.
The critical difference between CJC-1295 and native GHRH is metabolic stability. Native GHRH has a half-life of roughly 7–10 minutes in human plasma — it’s broken down rapidly by dipeptidyl peptidase-IV (DPP-IV) and cleared quickly. CJC-1295 incorporates two key modifications designed to resist this degradation:
-
Amino acid substitutions at positions 2, 8, 15, and 27 of the GHRH(1–29) sequence that reduce DPP-IV cleavage.
-
The DAC moiety — a reactive linker that forms a covalent bond with lysine residues on serum albumin, effectively creating a circulating reservoir of the peptide.
The result, as PMID: 15817669 demonstrated in their original characterization work, is a GHRH analog with dramatically prolonged bioactivity. In animal models, CJC-1295 maintained elevated GH and insulin-like growth factor 1 (IGF-1) levels for extended periods after a single administration — far longer than unmodified GHRH(1–29).
This mechanism also means CJC-1295 works with the body’s natural pulsatile GH architecture rather than replacing it. Unlike exogenous GH administration, which produces a non-physiological, continuous signal, CJC-1295 may support the existing pattern of GH pulses by amplifying the GHRH signal that triggers each one. Research suggests this distinction could be meaningful, though direct comparative clinical data remains limited.
Comparing CJC-1295 Suppliers: Key Criteria
Now for the practical question. Whether you’re sourcing CJC-1295 for in vitro work, animal studies, or simply maintaining a well-documented reference compound library, the supplier you choose matters. Here are the factors that separate reliable vendors from risky ones.
Third-Party Testing and Certificates of Analysis
This is the single most important criterion. Any reputable research peptide supplier should provide a Certificate of Analysis (COA) for each batch of CJC-1295 they sell. The COA should include:
-
HPLC purity percentage (look for ≥98% or higher for research-grade peptides)
-
Mass spectrometry confirmation (MALDI-TOF or ESI-MS verifying the correct molecular weight)
-
Endotoxin testing data (especially important for any in vivo work)
-
Identity of the testing laboratory — ideally a third-party, independent analytical lab rather than the vendor’s own in-house facility
If a supplier doesn’t provide batch-specific COAs, or if their COA doesn’t name the testing lab, consider that a significant red flag.
Purity Standards and Methodology
Not all “99% purity” claims are created equal. The analytical method matters:
-
Reverse-phase HPLC is the standard for peptide purity assessment.
-
Purity should be reported as the area under the main peak relative to total peak area.
-
Some vendors report purity by weight, which can be misleading if residual moisture or counter-ions inflate the mass.
A well-prepared CJC-1295 supplier comparison can help you cross-reference which vendors use independent HPLC analysis versus self-reported figures.
Pricing Per Milligram
CJC-1295 pricing in 2026 varies considerably — anywhere from roughly $15 to $60+ per milligram depending on the vendor, quantity, and claimed purity. Here’s a simplified comparison of pricing tiers:
| Tier | Approximate Price/mg | Typical Features |
|---|---|---|
| Budget | $12–$20 | May lack third-party COAs; less transparent sourcing |
| Mid-range | $20–$35 | Batch-specific COAs; established reputation in research community |
| Premium | $35–$60+ | Extensive testing documentation; COA from recognized independent labs |
Price alone shouldn’t drive the decision. A cheap vial with no COA is worth less than nothing if the contents are degraded, mislabeled, or contaminated. Conversely, the most expensive option isn’t automatically the purest — always verify the documentation independently.
Product Form and Storage
CJC-1295 is almost universally sold as a lyophilized (freeze-dried) powder. This is the correct form for long-term stability. Vendors who sell pre-reconstituted solutions raise concerns about degradation during storage and shipping.
Check whether the supplier:
-
Ships with cold packs or insulated packaging (peptides are heat-sensitive)
-
Recommends storage at –20°C for long-term stability
-
Clearly labels the net peptide content per vial (not just total vial weight, which includes excipients like mannitol)
Shipping Speed and Handling
For a lyophilized peptide, short transit times at ambient temperature are generally acceptable. However, if a supplier ships from overseas with a 2–3 week transit window during summer months, that’s a meaningful concern. Look for vendors who:
-
Offer domestic shipping from within your country or region
-
Provide tracking information
-
Use appropriate packaging materials
Reputation and Transparency
Vendor longevity counts. Suppliers that have been operating for several years, have a visible presence in research communities, and respond to technical questions are generally more reliable than fly-by-night operations. Some practical ways to assess reputation:
-
Review forums and research communities — not as absolute truth, but as data points.
-
Responsiveness to questions — can the vendor answer basic questions about their sourcing and testing?
-
Transparency about limitations — a vendor that states “research use only” clearly and doesn’t imply therapeutic benefit is generally more trustworthy than one making bold health claims.
What to Watch Out For
A few recurring warning signs in the research peptide space:
-
No COA available, or COA without a named third-party lab. This is the most common issue. If the testing was done in-house with no external verification, treat the purity figure with skepticism.
-
Unrealistic purity claims. If every product on the site claims “99.9%+ purity” across dozens of different peptides, that’s suspiciously uniform. Actual batch-to-batch variation is normal; pretending it doesn’t exist is not.
-
Therapeutic or medical claims. Any supplier marketing CJC-1295 as a treatment, therapy, or supplement for human use is operating outside regulatory norms and may not be prioritizing quality control. Research-grade peptides should be sold explicitly for research purposes.
-
Abnormally low pricing. If a price seems too good to be true, ask why. Synthetic peptides require significant resources to produce and verify. Dramatically below-market pricing may indicate diluted products, skipped analytical steps, or both.
Frequently Asked Questions
What is the difference between CJC-1295 and CJC-1295 with DAC?
The “with DAC” designation refers to the Drug Affinity Complex — a chemical modification that allows the peptide to bind to albumin in the bloodstream, extending its half-life significantly.
Some vendors use “CJC-1295” to mean CJC-1295 with DAC, while others use “mod GRF 1-29” or “CJC-1295 without DAC” to refer to the shorter-acting GHRH(1–29) analog with only the amino acid substitutions but no albumin-binding moiety. These are distinct compounds with different pharmacokinetic profiles. Always confirm which version you’re ordering.
How should CJC-1295 be stored?
Lyophilized CJC-1295 powder should be stored at –20°C for long-term stability, protected from light and moisture. Once reconstituted with bacteriostatic water, most references suggest refrigeration at 2–8°C and use within a defined window (typically weeks, depending on the formulation) to minimize degradation. Follow the specific storage guidance provided on the product’s COA or technical data sheet.
Is CJC-1295 legal to purchase for research?
In most jurisdictions, CJC-1295 is available as a research chemical and is not classified as a controlled substance. However, it is not approved by the FDA (or equivalent agencies in other countries) for human therapeutic use. Regulatory status can vary by country and is subject to change. Researchers should verify the current legal status in their jurisdiction before ordering.
Why does pricing vary so much between suppliers?
Several factors drive price variation: the cost of independent analytical testing (which adds to overhead), the scale of production, shipping and cold-chain logistics, and the supplier’s margin structure.
Some vendors invest heavily in batch-specific third-party testing and charge accordingly; others cut those corners. Pricing alone doesn’t indicate quality, but extremely low pricing should prompt questions about what testing may have been skipped.
Can I verify a supplier’s COA independently?
Yes, and it’s good practice to do so. If a COA lists a specific testing laboratory, you can often contact that lab to confirm the report is legitimate. Some COAs include report numbers or barcodes for verification. If a vendor resists providing a COA or offers only generic, non-batch-specific documentation, that should give you pause.